Vera Therapeutics Inc is a clinical stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VERA is expected to report earnings to fall 3.17% to -122 cents per share on March 19
Q4'25
Est.
$-1.22
Q3'25
Missed
by $0.11
Q2'25
Missed
by $0.38
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.09
The last earnings report on November 05 showed earnings per share of -125 cents, missing the estimate of -114 cents. With 172.75K shares outstanding, the current market capitalization sits at 1.81B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VERA showed earnings on November 05, 2025. You can read more about the earnings report here.